Depression in Osteoarthritis: Current Understanding.

Area of Science:

• Rheumatology
• Psychiatry
• Comorbidity Research

Background:

• Depression is a common comorbidity with osteoarthritis (OA), negatively impacting patient prognosis and quality of life.
• Current clinical management of OA patients with depression is often ineffective.
• Understanding the interplay between OA and depression is critical for improving patient care.

Purpose of the Study:

• To highlight the co-occurrence of depression and OA for healthcare providers.
• To review recent literature (past 10 years) on depression in OA.
• To inform clinical practice regarding screening and management.

Main Methods:

• Systematic literature review focusing on the past decade.
• Analysis of studies on prevalence, risk factors, and impact of depression in OA.
• Examination of comorbidity mechanisms, screening, and non-pharmacological treatments.

Main Results:

• High pain, poor function, multiple OA sites, and slow gait are associated with depression in OA patients.
• Pathophysiology remains unclear, with potential roles for immune inflammation, brain changes, and psychosocial factors.
• Depression is treatable with early intervention, but OA comorbidities require tailored approaches.

Conclusions:

• Healthcare providers should increase attention to depressive symptoms in OA patients.
• Individualized, comprehensive treatment plans integrating mental health assessments are recommended.
• Multidisciplinary team-based care is essential for optimizing outcomes in comorbid OA and depression.